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Abstract 18	
Resource-based trade-offs occur when investment in one fitness-related trait diverts energy 19	
away from other traits. The extent to which such trade-offs are shaped by limits on the rate of 20	
conversion of energy ingested in food (e.g. carbohydrates) into chemical energy (ATP) by 21	
oxidative metabolism rather than by the amount of food ingested in the first place is, 22	
however, unclear. Here we tested whether the ATP required for mounting an immune 23	
response will lead to a trade-off with ATP available for physical activity in mosquitofish 24	
(Gambusia holbrooki). To this end, we challenged fish either with lipopolysaccharide (LPS) 25	
from E. coli or with Sheep Red Blood Cells (SRBC), and measured oxygen consumption at 26	
rest and during swimming at maximum speed. Relative to saline-injected controls, only LPS-27	
injected fish showed a significantly greater resting metabolic rate two days post-challenge 28	
and significantly higher maximal metabolic rates two and seven days post-challenge. This 29	
resulted in a significantly greater metabolic scope two days post-challenge, with LPS-fish 30	
transiently overcompensating by increasing maximal ATP production more than would be 31	
required for swimming in the absence of an immune challenge. LPS-challenged fish therefore 32	
increased their production of ATP to compensate physiologically for the energetic 33	
requirements of immune functioning. This response would avoid ATP shortages and allow 34	
fish to engage in an aerobically-challenging activity (swimming) even when simultaneously 35	
mounting an immune response. Nevertheless, relative to controls, both LPS- and SRBC-fish 36	
displayed reduced body mass gain one week post-injection, and LPS-fish actually lost mass. 37	
The concomitant increase in metabolic scope and reduced body mass gain of LPS-challenged 38	
fish indicates that immune-associated trade-offs are not likely to be shaped by limited 39	
oxidative metabolic capacities, but may instead result from limitations in the acquisition, 40	
assimilation or efficient use of resources. 41	
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Introduction  44	
Pathogens can represent intense selection pressures for their hosts [1, 2].  Despite this, the 45	
evolution of host resistance through the activation of a protective immune response may be 46	
constrained by the energetic costs of immune functioning and trade-offs with other fitness-47	
related traits [3-6]. A growing number of studies have provided evidence of costly immune 48	
responses to inert antigens, with immune-challenged individuals showing increased 49	
nutritional intake [7, 8] and body mass loss [9, 10] compared to controls. Because hosts 50	
usually have access to limited resources, the energy allocated to fuel immune responses may 51	
be diverted away from other fitness-related functions, such as growth, reproduction and 52	
maintenance [3]. Accordingly, immune challenges have been shown to be associated with 53	
reduced locomotor performance [11, 12] and lowered investments in reproduction and growth 54	
[13, 14]. However, while energetic constrains are often assumed to mediate life history trade-55	
offs [3], the physiological processes by which this might occur still remain to be elucidated. 56	
 57	
Previous studies quantifying the energetic cost of immunity have focused on measuring 58	
changes in basal metabolic rates following immune challenge [9, 15, 16]. Basal (or resting 59	
when measured under less restrictive circumstances) metabolic rates reflect the rate of ATP 60	
hydrolysis required to maintain cellular processes during physical inactivity [17]. For 61	
instance, vaccinated rainbow trout (Oncorhynchus mykiss) displayed higher routine metabolic 62	
rates, which in fish can be indicative of basal metabolism, than controls [18], with rates 63	
increasing by ~20% 223° days post-vaccination [19]. Similarly, four species of insects 64	
(Tenebrio molitor, Acheta domesticus, Cotinis nitida and Periplaneta americana) showed an 65	
increase in metabolic rate by up to 28% following the induction of an encapsulation response 66	
[20]. Cutrera et al [21] reported that tuco-tucos (Ctenomys talarum) experimentally-67	
challenged with Sheep Red Blood Cells (SRBC) experienced a 20-35% increase in metabolic 68	
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rate, which was equivalent to a 15% increase in daily energetic expenditure. Martin et al. [22] 69	
and Eraud et al. [23] found that the increase in basal metabolic rate displayed by collared 70	
doves (Streptopelia decaocto) and house sparrows (Passer domesticus) following injections 71	
with inert antigens was of a magnitude similar to that required to produce half an egg per day 72	
and to maintain an optimal body temperature at an ambient temperature 1-2°C below thermo-73	
neutrality, respectively. While immune responses have thus been shown to increase the 74	
resting metabolic rate, it remains to be determined whether such immune-triggered increase 75	
in ATP use at rest means that less ATP is available for engaging in other aerobically-76	
challenging activities. 77	
 78	
The level of energy that an individual can allocate to fitness-related activities such as  79	
reproduction, foraging and engaging in behavioural interactions, can be estimated by the 80	
aerobic metabolic scope [24-26]. The aerobic metabolic scope is defined as the difference 81	
between the maximal metabolic rate, which reflects maximal mitochondrial flux [24], and the 82	
resting metabolic rate, and therefore represents the metabolic capacity to engage in 83	
aerobically-challenging activities [27]. Metabolic scopes may decline either when there is an 84	
increase in the resting metabolic rate or when there is a decrease in the maximal metabolic 85	
rate. Hence, if metabolic maintenance costs increase, the resultant reduction in metabolic 86	
scope can create an allocation trade-off [28]. Decreases in the amount of energy available to 87	
other activities may, however, be counterbalanced physiologically though an increase in the 88	
capacities of mitochondrial metabolic pathways [26, 29, 30]. While such compensatory 89	
responses may abolish ATP shortages, trade-offs may still persist if investment in multiple 90	
aerobically-challenging activities depletes storages of ingested chemical energy with 91	
detrimental consequences for body condition.  92	
 93	
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Here we examined the energetic basis of immune-associated resource allocation trade-offs in 94	
wild-caught, female mosquitofish (Gambusia holbrooki). Individuals were challenged either 95	
with lipopolysaccharides (LPS) isolated from Escherichia coli or with Sheep Red Blood Cells 96	
(SRBC) to investigate how differences in the type of immune response elicited may constrain 97	
energetic investments in other functions [21, 31-33]. Although fish are thought to be less 98	
sensitive to endotoxins such as LPS than other vertebrates [34-36], LPS-challenges in fish in 99	
vivo and in vitro nevertheless induced a strong inflammatory response [37, 38], and increased 100	
the production of cytokines and acute phase proteins, as well as stimulated T and B 101	
lymphocytes, macrophages and complement systems [25]. For example, the expression of 102	
cytokines in a monocyte-macrophage lineage of rainbow trout was detectable 6h after 103	
exposure to E. coli LPS and increased over 24h [29, 32]. LPS also induces antibody 104	
production, which  in the brown trout (Salmo trutta) was detectable on day 14 post-injection 105	
[39]. However, antigen-binding and antibody-secreting cells were detected in the spleen and 106	
kidney of these fish as early as 2 and 4 days after injection, with peaks reached between day 107	
14 and 18 post-injection [40]. SRBC, on the other hand, induced a non-pathogenic T and B-108	
cell dependent antibody response [31]. Brown trout immunized with SRBC displayed 109	
detectable levels of antigen-binding and antibody-secreting cells on day 6 post-injection, with 110	
levels peaking on day 12 [40]. Levels of antibody-producing cells were detectable as early as 111	
day 5 and peaked on day 10 in the Mozambique tilapia (Oreochromis mossambicus) [41]. 112	
 113	
First, we predicted that if immune responses were energetically costly, then immune-114	
challenged individuals would exhibit higher resting metabolic rates than controls. Second, we 115	
tested whether limits on ATP production and the amount of ATP available can give rise to 116	
immune-associated trade-offs. We predicted that, if this were the case, immune-challenged 117	
individuals should experience a reduction in metabolic scope relative to controls. Conversely, 118	
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if immune-associated trade-offs are shaped by a limited availability of ingested energetic 119	
resources, then immune activation should instead be associated with a reduction in body 120	
mass. 121	
 122	
Material and methods 123	
STUDY ANIMALS 124	
Wild invasive mosquitofish were captured in July 2011 from natural ponds on private land 125	
near Perpignan (42.698°N, 2.895°E) in southern France, with permission from local 126	
landowners. Animals were immediately brought back to the laboratory at the Station 127	
d’Ecologie Expérimentale du CNRS in Moulis (Ariège, France), where they were housed in 128	
large containers (100 fish at approximately 1 fish/L), with a mixture of water from their 129	
capture sites and aged tap water. The females used in this study were house individually (in 130	
300×250×200 mm tanks) so that we could follow individuals. Females were habituated to 131	
their individual tanks for two weeks before the start of the experiment. At the time of capture, 132	
water temperature at the sites of capture varied between 28-30oC; fish were therefore kept at 133	
30oC in the laboratory throughout the habituation and experimentation phases. Because 134	
female mosquitofish store sperm and will be mated immediately upon reaching maturity [19], 135	
we categorized females based on the shape and distension of their abdomen to ensure that all 136	
individuals used were at a similar early stage of pregnancy [for detailed methods see 42] [26].  137	
Fish were fed to satiety with commercial fish flakes once per day. Food was withheld 24 h 138	
prior to immune-treatment and prior to all measurements of metabolic rates. This ensured that 139	
fish were in a post-absorptive state and therefore fit the requirement for basal metabolic rate 140	
measurement (i.e., calm, motionless and post-absorptive). 141	
 142	
  143	
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IMMUNE CHALLENGE 144	
After approximately two weeks in captivity, females were randomly assigned to experimental 145	
or control groups (experimental LPS-injected: N=10; experimental SRBC-injected: N=9; 146	
controls: N=10). Individuals were challenged with an intra-peritoneal injection of LPS 147	
(Sigma; St. Louis, USA; L4005; 10µg/g fish at 1g/L [43]) or SRBC (Sigma R3378; 20µg/g 148	
fish at 1g/L [41, 44]) for experimental treatments, and 0.01mL of saline solution (PBS) for 149	
controls. Prior to injection, all fish were lightly anesthetized in a clove oil solution, and after 150	
injection animals were placed immediately in aged tap-water where they recovered within 1-2 151	
minutes. We recorded total body length using callipers (Mitutoyo, Kawasaki, Kanagawa, 152	
Japan; precision: ±0.05 mm) at the start of the experiment, and we measured body mass at the 153	
time of injection (hereafter: initial mass) and again after 7 days (~168 hours) using an 154	
electronic balance (Ohaus, Brooklyn, NY, USA; precision: ±0.01 g). 155	
 156	
OXYGEN CONSUMPTION 157	
In fish, the immune response to LPS is known to occur within hours of injection and last for 158	
at least 2 weeks [29, 32, 39]. On the other hand, antibody responses to SRBC can become 159	
detectable 5-6 post-immune challenge and peak 10-12 day post-injection [40, 41]. 160	
Consequently, we measured resting and maximal metabolic rates at 24h, 48h and 168h (7 161	
days) post-challenge in LPS-exposed individuals and control fish, and at 7 days only in 162	
SRBC-exposed ones.  Oxygen consumption is a commonly-used, indirect measure of 163	
metabolic rates [45]. Oxygen consumption was measured according to published methods 164	
[42] with a fibre-optic oxygen system (Fibox 3, Presens, Regensburg, Germany) monitoring 165	
sensor spots (Presens, Germany) attached to the insides of respirometers according to the 166	
manufacturers’ instructions. For resting oxygen consumption measurements, we allowed fish 167	
to rest in a cylindrical glass respirometer (245 ml volume) placed into a darkened tank for 45-168	
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60 minutes.  We then sealed the respirometer, making sure not to disturb the fish, and let the 169	
fish rest for a further 10-15 minutes before recording the decrease in oxygen over a 7-10 170	
minute period or until a steady rate of oxygen decrease was established; we followed the 171	
decrease in oxygen levels within the respirometer in real-time.  172	
 173	
Maximal rates of oxygen consumption were determined in a cylindrical glass respirometer 174	
(415 ml) placed on a magnetic stirrer [42]. A magnetic stirbar within the respirometer created 175	
water flow that could be adjusted with the control on the magnetic stirrer.  Turbulence and 176	
eddies within the respirometer were minimised by a central column suspended from the lid.  177	
Fish were placed into the respirometer and the speed was ramped up slowly until fish swam 178	
steadily, but occasionally had to struggle to maintain their position in the water column, i.e. 179	
fish occasionally went backwards in the water column and had to engage in burst swimming 180	
to regain their position, indicating near maximal swimming speeds.  Oxygen consumption 181	
was measured during 6-8 minutes of swimming at that speed.  Rates of oxygen consumption 182	
(in µmol g-1 min-1) were determined as the slope of the decrease in oxygen content divided by 183	
the fish body mass and multiplied by the volume of the container [45]. We calculated 184	
exercise-induced metabolic scope as the difference between resting and swimming oxygen 185	
consumption.  186	
 187	
STATISTICAL ANALYSES 188	
All statistical analyses were performed using SAS software version 9.3 (SAS Inc., Cary, NC). 189	
When required, data were log10-transformed before analyses to fulfil assumptions of 190	
normality and homoscedascity. Because metabolic rates are generally influenced by body 191	
mass (Hill et al 2012), we initially tested such an association using a general linear model 192	
with a normal error structure and by specifying initial mass as an explanatory term. We then 193	
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tested whether resting and maximal metabolic rates, and metabolic scopes of LPS-injected 194	
fish differed from those of controls using multivariate general linear mixed models with 195	
treatment (LPS or PBS), time and their interaction, and with initial mass as fixed effects, and 196	
with individual as the random effect; for each time point, differences between LPS-197	
challenged and control fish were contrasted within the same model using the “estimate” 198	
statement. Non-significant interactions were removed from final models. To examine how 199	
SRBC-injected fish differed in their resting and maximal metabolic rates and in their 200	
metabolic scope relative to controls and to LPS-fish, we conducted general linear models 201	
with treatment (SRBC, LPS or PBS) and initial mass as fixed effects; between-treatment 202	
differences were contrasted within the models using the “estimate” statement. Treatment 203	
effects on changes in body mass over the course of the experiment were conducted using a 204	
general linear model with the difference in body mass between 0 and 7 days post-injection as 205	
the dependent variable and with treatment and initial mass as fixed effects; between-treatment 206	
differences were contrasted using the “estimate” statement. 207	
 208	
Results 209	
EFFECTS OF IMMUNE TREATMENT ON RESTING AND MAXIMAL METABOLIC 210	
RATES 211	
Resting and maximal rates of oxygen consumption and the metabolic scope were all 212	
significantly associated with body mass, regardless of the treatment (GLM; resting metabolic 213	
rate: F1,67=9.77, p=0.0026, maximal metabolic rate: F1,67=45.01, p<0.0001, metabolic scope: 214	
F1,67=26.6, p<0.0001). First, we investigated the metabolic cost of an immune response to 215	
LPS. LPS-injected fish displayed higher resting and maximal rates of oxygen consumption 216	
than saline-injected controls over the course of the experiment (GLMM; resting rates of 217	
oxygen consumption: treatment: F1,38=8.8, p=0.005, time: F2,38=1.2, p=0.319; initial mass: 218	
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F1,38=9.32, p=0.004; maximal rates of oxygen consumption: treatment: F1,38=6.14, p=0.018, 219	
time: F2,38=1.1, p=0.334, initial mass: F1,38=13.7, p<0.001; Table 1; Fig. 1a, b). Separate 220	
analyses of each time point revealed significant between-treatment differences in resting 221	
metabolic rates 24 h post-challenge and in maximal metabolic rate 48 h and 7 days post-222	
challenge (resting metabolic rate: 24 h: t36=2.41, p=0.021; 48 h: t36=1.22, p=0.230; 7 days: 223	
t36=1.97, p=0.057; maximal metabolic rate: 24h: t36=0.02, p=0.986; 48h: t36=2.88, p=0.007; 7 224	
days: t36=1.90, p=0.066). 225	
 226	
Table 1: Metabolic measures for immune-challenged (with LPS or SBRC) and control 227	
(saline-injected) mosquitofish. We provide raw means (in µmol/min/g) and standard 228	
deviations for resting and maximal metabolic rates and for metabolic scopes at 24h, 48h and 229	
7 days post-challenge with LPS, and at 7 days post-challenge with SRBC. 230	
Time post-treatment Metabolic measure Treatment 
  Control LPS SRBC 
24h Resting 0.163 ± 0.053 0.293 ± 0.174  
 Maximum 0.831 ± 0.147 0.932 ± 0.255  
 Scope 0.668 ± 0.147 0.640 ± 0.224  
48h Resting 0.202 ± 0.060 0.282 ± 0.083  
 Maximum 0.692 ± 0.124 1.038 ± 0.198  
 Scope 0.490 ± 0.110 0.756 ± 0.207  
7 days Resting 0.205 ± 0.078 0.322 ± 0.150 0.209 ± 0.082 
 Maximum 0.809 ± 0.133 1.196 ± 0.675 1.696 ± 0.786 
 Scope 0.605 ± 0.127 0.874 ± 0.579 1.488 ± 0.750 
 231	
  232	
Fig. 1: Resting (a) and maximal (b) rates of oxygen consumption and metabolic scope (c) of 233	
LPS-injected and PBS (control) fish 24h, 48h and 168h (7 days) after treatment. Values show 234	
predicted means (in µmol/min/g) with standard errors (* indicates p<0.05). 235	
 236	
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Second, we examined the metabolic cost of an immune response to SRBC and compared the 237	
metabolic rates of SRBC- and LPS-fish. Resting rates of oxygen consumption 7 days post-238	
injection differed significantly between treatments (GLM, treatment: F2,25=5.6, p<0.010, 239	
initial mass: F1,25=4.9, p=0.036; Table 1; Fig. 2a, b). However, between-treatment tests 240	
revealed that differences were significant between LPS and SRBC-fish only (t=3.17, 241	
p=0.004), with SRBC-fish displaying resting rates of oxygen consumption that were 50% 242	
lower than LPS-injected ones, but not between SRBC-fish and saline-injected controls (t=1.4, 243	
p=0.171). Treatment did not affect maximal rates of oxygen consumption 7 days post-244	
injection (GLM, treatment: F2,25=0.5, p=0.600, initial mass: F1,25=8.3, p=0.008), with no 245	
significant difference detected between SRBC-fish and either LPS-fish or controls (p>0.1). 246	
 247	
Fig. 2: Resting (a) and maximal (b) rates of oxygen consumption and metabolic scope (c) of 248	
SRBC-, LPS- and PBS-injected (control) fish 7 days after treatment. Values show predicted 249	
means (in µmol/min/g) with standard errors (** indicates p<0.01). 250	
 251	
EFFECTS OF IMMUNE TREATMENT ON METABOLIC SCOPES AND BODY MASS  252	
LPS-injected fish displayed a significantly greater metabolic scope over the course of the 253	
experiment than sham-injected controls (GLMM, treatment: F1,36=1.44, p=0.238, time: 254	
F2,36=0.8, p=0.460, treatment × time: F2,36=3.3, p=0.050, initial mass: F1,36=4.7, p=0.037; 255	
Table 1; Fig. 1c). Separate analyses of each time point revealed a significant difference 256	
between LPS-challenged and control fish 48h after treatment (24h: t36=-1.01, p=0.321; 48h: 257	
t36=2.32, p=0.026; 7 days: t36=1.04, p=0.306). Although SBRC-injected fish displayed higher 258	
metabolic scopes than controls 7 days post-injection, the effect of treatment on metabolic 259	
scopes at that time point was not significant (GLM, treatment: F2,25=0.8, p=0.443, initial 260	
mass: F1,25=5.7, p=0.025; Table 1; Fig. 2c), with no significant differences detected in any of 261	
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the pairwise comparisons (all p>0.1). There was a significant effect of treatment on mass 262	
change over the course of the experiment (GLM, treatment: F2,25=7.3, p=0.003, initial mass: 263	
F1,25=5.0, p=0.034; Fig. 3), with mass change differing significantly between LPS- and 264	
control fish (t=-3.7, p=0.001) and between SRBC- and control fish (t=2.8, p=0.010). LPS-fish 265	
lost on average over 4% of their body mass over the 7 days of the experiment (initial 266	
mass=0.73±0.21g; final mass=0.70±0.18g), but SRBC and control-fish increased their body 267	
mass by 5% and 8%, respectively (SRBC: initial mass=0.42±0.14g, final mass=0.44±0.17g; 268	
control: initial mass=0.90±0.24g, final mass=0.97±0.21g). 269	
 270	
Fig. 3: Mass change between the day of the injection (day 0) and 7 days after injection. 271	
Values show predicted means (in g) with standard errors (** indicates p≤0.01 and *** 272	
indicates p≤0.001). 273	
 274	
Discussion 275	
Our results show that experimental challenges with an inert antigen can give rise to changes 276	
in resting and maximal metabolic rates, with measurable consequences for metabolic scopes 277	
and hence the overall amount of ATP available to aerobically-challenging activities other 278	
than those at rest. Resting and maximal metabolic rates and the metabolic scope were 279	
significantly increased relative to controls in LPS-challenged fish only. Furthermore, 280	
immune-challenged fish gained significantly less body mass over the course of the 281	
experiment than controls, with LPS-fish actually losing body mass. Our results indicate that 282	
oxidative metabolic capacities can be increased in immune-challenged individuals, such that 283	
these individuals actually produce more ATP than would be needed for engaging in 284	
aerobically-challenging activities in the absence of an immune challenge. 285	
 286	
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The higher resting metabolic rate displayed by LPS-challenged individuals relative to 287	
controls corroborates the existence of an energetic cost associated with the immune response 288	
to LPS. LPS are immunogenic molecules found in the cell wall of gram-negative bacteria that 289	
can rapidly trigger a strong inflammatory response without causing infection [46]. In 290	
endotherms, injections with E. coli LPS are commonly used to assess the acute phase 291	
response, which occurs within hours of challenge and includes changes in body temperature 292	
(e.g., fever) and the expression of sickness behaviours [47-50]. Responses to LPS have been 293	
indirectly shown to be costly. For example, LPS-challenged individuals displayed decreased 294	
food intake, activity and growth, and exhibited reduced reproductive output [14, 15, 49, 51-295	
53]. Furthermore, direct energetic costs of LPS injections have been demonstrated as a 10 and 296	
20% increase in the resting metabolic rates of zebra finch and rats, respectively [15, 54]. In 297	
fish, LPS has been shown to induce a depletion of liver glycogen levels in yearling coho 298	
salmon (O. kisutch) and rainbow trout [55], and it is likely to be a potent agent of anorexia in 299	
gold fish (Carassius auratus auratus) [56]. Our results verify the metabolic cost of a 300	
response to LPS in fish, which can be maintained over the course of a week, but is higher 24h 301	
than 7 days post-challenge.  302	
 303	
On the other hand, the lack of significant difference in resting metabolic rates between 304	
SRBC-treated and control fish suggests either that the cost of immunity to SRBC is 305	
negligible or that it becomes detectable later than 7 days post-challenge. SRBC is a T cell-306	
dependent antigen commonly used to assay humoral immune responses, and anti-SRBC 307	
antibodies reach a peak 10 and 12 days after injection in brown trout and Mozambique 308	
tilapia, respectively [40, 41]. SRBC-injections were previously found to produce a 8.5% 309	
increase in the basal metabolic rate of collared doves 7 days after challenge [23], yet they did 310	
not affect body mass and molting in house sparrows (Passer domesticus) [57]. Similarly, 311	
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SRBC-injected greenfinches (Carduelis chloris) were shown to exhibit reduced activity, but 312	
no mass loss, 4 and 8 days post-challenge [58], suggesting that SRBC induces only a mild 313	
sickness response. While the metabolic costs and consequences of the immune response 314	
mounted by mosquitofish against SRBC still remain to be determined, the fact that SRBC-315	
fish gained significantly less mass over the course of the experiment than controls suggests 316	
that a challenge with SRBC induces measurable energetic costs the first week post-injection.  317	
 318	
Immune-challenged mosquitofish did not display a decreased metabolic scope relative to 319	
saline-injected controls, indicating that immune functioning did not give rise to a trade-off at 320	
the level of ATP production and use. In fact, not only were metabolic scopes not decreased in 321	
LPS-injected fish, but they were actually greater than those of controls, indicating that 322	
individuals actually boosted their levels of energy available to physical activity. This increase 323	
in metabolic scope was significant only at 48h post-injection in LPS-fish, indicating that this 324	
process is not immediate and may only be transitory. One explanation for such 325	
overcompensation is that immune-challenged fish require more ATP to sustain swimming 326	
than saline-injected controls. LPS has indeed been shown to decrease the efficiency of 327	
carbohydrate catabolism by skeletal muscles, that is the ratio between ATP use and power 328	
output, giving rise to greater oxygen consumption during activity, and to stimulate muscle 329	
wasting leading to muscle dysfunction [59-61]. In fish, white skeletal muscle is mostly 330	
anaerobic and used primarily in burst swimming, while red skeletal muscle is aerobic and 331	
involved in sustained swimming speed [62]. Gilthead seabream (Sparus aurata) challenged 332	
with LPS displayed strong transcriptomic responses in their white and red skeletal muscles 333	
24h and 72h post-injection [11]. Protein synthesis and carbohydrate catabolism were strongly 334	
increased in white muscle 24h post-LPS administration, which suggested in part that LPS 335	
may initially stimulate energy production through glycolysis; these patterns were, however, 336	
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reversed at 72h possibly indicating muscle atrophy. Genes involved in aerobic metabolism 337	
and protein synthesis, on the other hand, were up-regulated 72h post-challenge in red muscle 338	
[11]. Similar increases in carbohydrate metabolism were observed in the fast muscle fibres of 339	
rainbow trout following challenge with LPS [63]. Whether the increased aerobic metabolism 340	
that we detected in mosquitofish 48h post-immune challenge with LPS, allowed fish to swim 341	
at an equivalent speed or faster than control fish was not explored in this study. The capacity 342	
to increased aerobic metabolism may be positively selected for if it facilitates parallel 343	
increases in two or more concurrent, aerobically-demanding activities, such as immunity and 344	
locomotion, that maximize survival and hence residual reproductive values [64, 65]. Future 345	
work is required to better understand the consequence of immune-associated increases in 346	
metabolic scope on locomotor performance (e.g., swim speed and duration) as well as its 347	
evolutionary significance for individual fitness. 348	
 349	
While immune functioning did not give rise to a trade-off in terms of metabolic scope, the 350	
lowered relative body mass of immune-challenged fish at the end of the experiment suggests 351	
that limited acquired food resources, or that impaired food assimilation or mitochondrial use 352	
of those resources [66], may instead drive trade-offs between immunity and other aerobic 353	
traits. For e.g., inflammatory responses have indeed been found to cause mitochondrial 354	
dysfunction [67] and a lower efficiency of mitochondria as a result of proton leak, for 355	
example, would mean that greater amounts of substrate and ultimately food or energy 356	
reserves) have to be oxidised to achieve a given ATP output [66]. Fish that were challenged 357	
with LPS- or SRBC- both exhibited reduced body mass gain relative to controls over the 1 358	
week duration of the experiment, with LPS-fish actually loosing mass and SBC-fish gaining 359	
>4 times less mass than controls. Divergence in mass change between SRBC- and LPS-fish is 360	
likely to stem, in part, from LPS-induced adaptive anorexia, which may have prevented a 361	
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compensation of the energetic costs of immunity through greater food intake [56]. Anorexia 362	
is, indeed, a host defence mechanism against bacterial infections [68] and a typical 363	
component of the sickness response to LPS [15, 51], but not SRBC [57, 58].  364	
  365	
Our data show that plasticity in oxidative metabolism is at least a short term response to an 366	
immune challenge that can increase the fitness of individuals by maintaining locomotor 367	
performance, reproductive activity, and similar aerobically-demanding functions. The 368	
benefits of such upregulated ATP production, however, are expected to diminish with muscle 369	
loss and as body condition decreases below critical levels. 370	
 371	
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